"Salvage Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases.
| Descriptor ID |
D016879
|
| MeSH Number(s) |
E02.895
|
| Concept/Terms |
Salvage Therapy- Salvage Therapy
- Salvage Treatment
- Salvage Treatments
- Treatment, Salvage
- Treatments, Salvage
- Therapy, Salvage
- Salvage Therapies
- Therapies, Salvage
|
Below are MeSH descriptors whose meaning is more general than "Salvage Therapy".
Below are MeSH descriptors whose meaning is more specific than "Salvage Therapy".
This graph shows the total number of publications written about "Salvage Therapy" by people in this website by year, and whether "Salvage Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 3 | 4 |
| 1997 | 0 | 3 | 3 |
| 2000 | 2 | 1 | 3 |
| 2001 | 2 | 2 | 4 |
| 2002 | 1 | 2 | 3 |
| 2003 | 4 | 8 | 12 |
| 2004 | 3 | 4 | 7 |
| 2005 | 2 | 4 | 6 |
| 2006 | 1 | 3 | 4 |
| 2007 | 5 | 3 | 8 |
| 2008 | 5 | 3 | 8 |
| 2009 | 1 | 4 | 5 |
| 2010 | 8 | 6 | 14 |
| 2011 | 2 | 3 | 5 |
| 2012 | 4 | 2 | 6 |
| 2013 | 1 | 4 | 5 |
| 2014 | 4 | 3 | 7 |
| 2015 | 3 | 4 | 7 |
| 2016 | 5 | 1 | 6 |
| 2017 | 9 | 2 | 11 |
| 2018 | 2 | 5 | 7 |
| 2019 | 3 | 4 | 7 |
| 2020 | 5 | 4 | 9 |
| 2021 | 3 | 5 | 8 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 2 | 2 |
| 2024 | 2 | 0 | 2 |
| 2025 | 1 | 2 | 3 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Salvage Therapy" by people in Profiles.
-
Long-term patient-reported outcomes and toxicity following salvage radiotherapy for biochemical recurrence after radical prostatectomy. Cancer. 2026 Sep 15; 132(18):e70609.
-
Pathologic failure and salvage approaches following focal therapy for localized prostate cancer. Can J Urol. 2026 Aug 21; 33(4):799-810.
-
Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents. Leuk Lymphoma. 2025 Dec; 66(13):2437-2447.
-
Posterior Approach to Sacroiliac Joint Fusion as a Salvage Procedure: A Case Report. Pain Med Case Rep. 2025 Aug; 9(4):197-199.
-
The Evolving Management of Radiorecurrent Prostate Cancer. Semin Radiat Oncol. 2025 Jul; 35(3):450-462.
-
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting. Urol Oncol. 2025 03; 43(3):135-146.
-
Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database. Radiother Oncol. 2024 12; 201:110532.
-
The Neurostimulation Appropriateness Consensus Committee (NACC)®: Recommendations for Spinal Cord Stimulation Long-Term Outcome Optimization and Salvage Therapy. Neuromodulation. 2024 Aug; 27(6):951-976.
-
A nationwide analysis of salvage surgery for laryngeal cancer in the elderly. Head Neck. 2023 11; 45(11):2915-2924.
-
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Leukemia. 2023 04; 37(4):799-806.